SecSonar.com

Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Anixa Biosciences, Inc. (ANIX) is a Biotechnology company based in US with a market capitalization of $92.2M. Free cash flow was negative at -$7.2M. This page tracks ANIX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 5 employees · IPO Oct 7, 1983

Valuation

Valuation & price

$2.82 · as of May 17, 2026 · -46.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.08

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.22$3.81$2.40Jul 25Dec 25Jul 26Jul 7, 25$3.21Jul 9, 25$3.15Jul 11, 25$3.14Jul 15, 25$3.20Jul 17, 25$3.35Jul 21, 25$3.43Jul 23, 25$3.38Jul 25, 25$3.22Jul 29, 25$3.10Jul 31, 25$3.06Aug 4, 25$3.26Aug 6, 25$3.10Aug 11, 25$2.94Aug 13, 25$3.05Aug 15, 25$2.97Aug 19, 25$2.97Aug 21, 25$2.95Aug 25, 25$3.00Aug 27, 25$2.95Aug 29, 25$2.99Sep 3, 25$2.99Sep 5, 25$2.97Sep 9, 25$2.98Sep 11, 25$2.95Sep 16, 25$3.60Sep 18, 25$3.37Sep 22, 25$3.49Sep 24, 25$3.44Sep 26, 25$3.40Sep 30, 25$3.30Oct 2, 25$3.29Oct 6, 25$3.25Oct 8, 25$4.44Oct 10, 25$4.33Oct 14, 25$4.33Oct 16, 25$4.40Oct 21, 25$4.18Oct 23, 25$4.18Oct 27, 25$4.33Oct 29, 25$4.16Oct 31, 25$4.13Nov 4, 25$3.97Nov 6, 25$4.06Nov 10, 25$4.19Nov 12, 25$4.39Nov 14, 25$4.11Nov 18, 25$4.10Nov 20, 25$4.40Nov 25, 25$4.32Nov 28, 25$4.59Dec 2, 25$4.20Dec 4, 25$4.74Dec 8, 25$5.22Dec 10, 25$5.13Dec 12, 25$3.58Dec 16, 25$3.57Dec 18, 25$3.24Dec 22, 25$3.37Dec 24, 25$3.42Dec 29, 25$3.18Jan 2, 26$3.16Jan 6, 26$3.18Jan 8, 26$3.42Jan 12, 26$3.16Jan 14, 26$3.31Jan 16, 26$3.19Jan 21, 26$3.17Jan 23, 26$3.26Jan 27, 26$3.08Jan 29, 26$3.10Feb 2, 26$2.94Feb 4, 26$2.92Feb 9, 26$2.98Feb 11, 26$2.84Feb 13, 26$2.82Feb 18, 26$2.90Feb 20, 26$2.88Feb 24, 26$3.00Feb 26, 26$3.04Mar 2, 26$2.96Mar 4, 26$2.91Mar 6, 26$2.85Mar 10, 26$2.98Mar 12, 26$2.86Mar 17, 26$2.89Mar 19, 26$2.77Mar 23, 26$2.61Mar 25, 26$2.70Mar 27, 26$2.55Mar 31, 26$2.58Apr 2, 26$2.55Apr 7, 26$2.69Apr 9, 26$2.74Apr 13, 26$2.85Apr 15, 26$2.93Apr 17, 26$2.91Apr 22, 26$3.14Apr 24, 26$3.05Apr 28, 26$3.01Apr 30, 26$3.00May 4, 26$3.06May 6, 26$3.06May 8, 26$3.00May 12, 26$2.95May 14, 26$2.89May 18, 26$2.76May 20, 26$2.73May 22, 26$2.79May 28, 26$2.70Jun 1, 26$2.70Jun 3, 26$2.52Jun 5, 26$2.48Jun 9, 26$2.40Jun 11, 26$2.48Jun 15, 26$2.48Jun 17, 26$2.69Jun 22, 26$2.77Jun 24, 26$2.74Jun 26, 26$2.79Jul 2, 26$3.29
$2.3552-week range$5.22
Loading valuation history…

Fundamentals

Key fundamentals

$92.2M

Market cap

—

Revenue growth (YoY)

23.3%

Gross margin

-$7.2M

Free cash flow (USD)

-$15M

Net debt

Net cash position

1.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$300.0KFY 2017$362.5KFY 2018$1.1MFY 2019$250.0KFY 2020$0.00FY 2021$512.0KFY 2022$0.00FY 2023$210.0KFY 2024$0.00FY 2025$0.00
$300K$0

Free cash flow by year

2016 → 2025

FY 2016$-3.5MFY 2017$-3.8MFY 2018$-4.3MFY 2019$-4.9MFY 2020$-6.2MFY 2021$-4.9MFY 2022$-6.5MFY 2023$-6.2MFY 2024$-7.3MFY 2025$-7.2M
-$3.5M-$7.2M

Gross margin by year

2021 → 2023

FY 202124.8%FY 202323.3%
24.8%23.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

2

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 10, 2026 (EPS $-0.07)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $7KTitterton Lewis H jr · Director · $7.5KJun 17, 2026Filing
  • Insider buyInsider Buy $52KKUMAR AMIT · Director, Chief Executive Officer · $52.5KJun 16, 2026Filing
  • Quarterly report10-Q FiledJun 10, 2026Filing

Questions

Frequently asked questions

What is Anixa Biosciences, Inc.'s market cap?

Anixa Biosciences, Inc. (ANIX) has a market capitalization of $92.2M.

What is ANIX's P/E ratio?

A meaningful P/E ratio is not available for ANIX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ANIX's price-to-book (P/B) ratio?

ANIX trades at 6.08 times book value per share.

When did Anixa Biosciences, Inc. last report earnings?

ANIX last reported earnings on June 10, 2026; the next date is not yet scheduled.

Are insiders buying ANIX stock?

Yes — SEC Form 4 filings show 2 open-market insider buys and 0 sells at Anixa Biosciences, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

FBIO

Fortress Biotech, Inc.

$93.3M

CAMP

CAMP4 Therapeutics Corporation

$93.6M

NRXS

NeurAxis, Inc.

$89.9M

ICCC

ImmuCell Corporation

$89.6M

ATRA

Atara Biotherapeutics, Inc.

$94.9M

DTIL

Precision BioSciences, Inc.

$89.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.